Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:PHASQ
日付受信時刻ニュースソース見出しコード企業名
2024/05/1705 : 32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2024/05/1705 : 28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/11/3006 : 55Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/11/1606 : 17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/10/0320 : 17Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/09/2721 : 52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/08/2601 : 34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/08/2601 : 31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/07/0105 : 21Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/3105 : 03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/1705 : 23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/04/0405 : 06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/03/2421 : 08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1507 : 07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1505 : 01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1504 : 27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/2322 : 34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/2120 : 10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/0306 : 20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/11/1606 : 21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/11/0505 : 44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:PHASQ

最近閲覧した銘柄